RedHill Biopharma (RDHL)
NASDAQ:RDHL
Holding RDHL?
Track your performance easily

RedHill Biopharma (RDHL) Financial Statements

817 Followers

RedHill Biopharma Financial Overview

RedHill Biopharma's market cap is currently ―. The company's EPS TTM is $-78.987; its P/E ratio is -0.11; RedHill Biopharma is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 17.55M$ 18.35M$ 18.24M
Gross Profit--$ 8.10M$ 9.35M$ 10.20M
EBIT--$ -3.92M$ -7.50M$ -13.23M
EBITDA--$ -1.83M$ -5.58M$ -11.09M
Net Income Common Stockholders--$ -35.70M$ -11.71M$ -17.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.57M$ 15.00K$ 15.22M$ 27.00M$ 28.86M
Total Assets$ 23.05M$ 158.87M$ 157.19M$ 167.97M$ 167.05M
Total Debt$ 1.17M$ 7.47M$ 120.83M$ 93.65M$ 95.01M
Net Debt$ -4.40M$ 7.46M$ 105.61M$ 66.64M$ 66.15M
Total Liabilities$ 20.98M$ 207.27M$ 203.22M$ 179.91M$ 172.29M
Stockholders Equity$ 2.07M$ -51.23M$ -46.03M$ -11.94M$ -5.24M
Cash Flow-
Free Cash Flow--$ -6.05M$ -16.74M$ -4.17M
Operating Cash Flow--$ -6.03M$ -16.58M$ -4.16M
Investing Cash Flow--$ -22.00K$ -163.00K$ 8.49M
Financing Cash Flow--$ -5.72M$ 14.92M$ -4.94M
Currency in USD

RedHill Biopharma Earnings and Revenue History

RedHill Biopharma Debt to Assets

RedHill Biopharma Cash Flow

RedHill Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis